Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine
Gould, R.J.; Murphy, K.M.; Snyder, S.H.
Molecular Pharmacology 25(2): 235-241
1984
ISSN/ISBN: 0026-895X PMID: 6422231 Document Number: 231386
Document emailed within 1 workday
Related Documents
Schoemaker, H.; Boles, R.G.; Roeske, W.R.; Yamamura, H.I. 1983: Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain Proceedings of the Western Pharmacology Society 26: 219-224Matsuda, S. 1991: Protective effects of calcium antagonist (nitrendipine) on calcium ionophore A23187-induced liver cell injury Bulletin of Tokyo Medical and Dental University 38(3): 35-44
Mack, W.M.; Zimányi, I.; Pessah, I.N. 1992: Discrimination of multiple binding sites for antagonists of the calcium release channel complex of skeletal and cardiac sarcoplasmic reticulum Journal of Pharmacology and Experimental Therapeutics 262(3): 1028-1037
Bellemann, P.; Ferry, D.; Lübbecke, F.; Glossman, H. 1981: 3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes Arzneimittel-Forschung 31(12): 2064-2067
Lopes, H.F.; Silva, H.B.; Bellotti, G.; Pillegi, F. 1990: Efficacy and tolerance of a new calcium-channel blocking agent (nitrendipine) in the treatment of arterial hypertension Arquivos Brasileiros de Cardiologia 54(3): 227-229
Takács, E.; Jellinek, H. 1990: The effect of calcium antagonist nitrendipine on the morphological picture of experimentally-produced myocardial injuries in rats Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 136(1-2): 97-111
Olsen, R.W.; Bergman, M.O.; Van Ness, P.C.; Lummis, S.C.; Watkins, A.E.; Napias, C.; Greenlee, D.V. 1981: Gamma-Aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites Molecular Pharmacology 19(2): 217-227
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Ullal, G.R. 1994: Dihydropyridine group of calcium channel antagonist in epilepsy Indian Journal of Physiology and Pharmacology 38(1): 43-46
Lubsen, J. 1998: The calcium channel antagonist debate: recent developments European Heart Journal 19 Suppl I: I3-I7
Lukas, R.J. 1990: Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites Journal of Pharmacology and Experimental Therapeutics 253(1): 51-57
Alemà, S.; Bianconi, A.; Castellani, L.; Fasella, P. 1982: X-ray absorption spectroscopy (EXAFS and XANES) a structural tool for calcium binding proteins: effect of Mg2+ on Ca2+ binding sites of troponin-C Progress in Clinical and Biological Research 102 Pt C: 47-57
Wynn, H.; Ramesh, M.; Matowe, W.C.; Wolowyk, M.W.; Knaus, E.E. 1988: Synthesis and calcium channel antagonist activity of 1,2-dihydropyridyl analogues of nifedipine Drug Design and Delivery 3(3): 245-256
Su, T.P. 1985: Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity Journal of Pharmacology and Experimental Therapeutics 232(1): 144-148
Shearman, L.P.; Collins, L.M.; Meyer, J.S. 1996: Characterization and localization of [125I]RTI-55-labeled cocaine binding sites in fetal and adult rat brain Journal of Pharmacology and Experimental Therapeutics 277(3): 1770-1783
Zobrist, R.H.; Mecca, T.E. 1990: 3H]TA-3090, a selective benzothiazepine-type calcium channel receptor antagonist: in vitro characterization Journal of Pharmacology and Experimental Therapeutics 253(2): 461-465
Ei-Fakahany, E.F.; Miller, E.R.; Abbassy, M.A.; Eldefrawi, A.T.; Eldefrawi, M.E. 1983: Alcohol modulation of drug binding to the channel sites of the nicotinic acetylcholine receptor Journal of Pharmacology and Experimental Therapeutics 224(2): 289-296
Ericsson, H.; Tholander, B.; Björkman, J.A.; Nordlander, M.; Regårdh, C.G. 1999: Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(5): 558-564
Davood, A.; Khodarahmi, G.; Alipour, E.; Dehpour, K.; Amini, M.; Shafiee, A. 2001: Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent Bollettino Chimico Farmaceutico 140(6): 381-386
Zahniser, N.R.; Molinoff, P.B. 1983: Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum Molecular Pharmacology 23(2): 303-309